FDA product code GGT: Assay, Erythropoietin
GGT is the FDA product code for assay, erythropoietin. It is a Class II device, regulated under 21 CFR 864.7250 and reviewed by the Hematology panel. FDA has cleared 20 510(k) submissions under GGT, 1 in the last five years, from 13 different applicants. The average 510(k) review took 222 days (median 210); 90 days on average over the last three years. FDA has posted 5 recalls for GGT devices, 4 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Assay, Erythropoietin |
| Device class | Class II |
| Regulation | 21 CFR 864.7250 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for GGT
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 269 |
| 2024 | 1 | 90 |
Compare with all 510(k) review times · Search every GGT clearance
Top GGT applicants
| Applicant | Clearances | Latest |
|---|---|---|
| R&D Systems, Inc. | 3 | 1994-07-19 |
| Beckman Coulter, Inc. | 2 | 2024-04-22 |
| Nichols Institute | 2 | 1996-05-29 |
| Genzyme Corp. | 2 | 1996-02-05 |
| Incstar Corp. | 2 | 1990-08-22 |
8 more applicants have GGT clearances. See the full list in Caduvo.
Most recent GGT clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K240182 | Beckman Coulter, Inc. | Access EPO | 2024-04-22 | 90 |
| K183088 | Axis-Shield Diagnostics Limited | ADVIA Centaur Erythropoietin (EPO) assay | 2019-08-02 | 269 |
| K052223 | Beckman Coulter, Inc. | ACCESS EPO ASSAY | 2006-10-06 | 417 |
| K992799 | Sangui Biotech, Inc. | SANGUI BIOTECH, INC. EPO (ERYTHROPOIETIN) ELISA KIT | 2000-06-07 | 293 |
| K983203 | Diagnostic Products Corp. | IMMULITE EPO, MODEL #'S LKEPZ & LKEP1 | 1999-07-12 | 301 |
Recalls for GGT devices
5 product recalls in 4 recall events; 4 initiated in the last five years and 3 still open. Most recent: 2025-02-03.
| Year | Recalls |
|---|---|
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Frequently asked questions
What is FDA product code GGT?
GGT is the FDA product code for assay, erythropoietin. It is a Class II device, regulated under 21 CFR 864.7250 and reviewed by the Hematology panel.
What device class is GGT?
Class II, regulation 21 CFR 864.7250. Typical premarket route: 510(k).
How long does a 510(k) take for product code GGT?
Across 20 cleared submissions the average was 222 days from receipt to decision (median 210).
Which companies have the most GGT clearances?
R&D Systems, Inc. (3); Beckman Coulter, Inc. (2); Nichols Institute (2); Genzyme Corp. (2); Incstar Corp. (2).
Have GGT devices been recalled?
Yes: 5 product recalls across 4 recall events; the most recent began 2025-02-03.
Next steps
- Run an FDA pathway report with predicate devices for product code GGT
- Run a recall and safety report across every GGT manufacturer
- Watch product code GGT for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times